tobramycin has been researched along with Libman-Sacks Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afifi, A; De Lord, D; Rasool, S | 1 |
| Auquier, L; Paolaggi, JB; Peltier, A | 1 |
1 review(s) available for tobramycin and Libman-Sacks Disease
| Article | Year |
|---|---|
[Rheumatology in 1971-72-73-74].
Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; B-Lymphocytes; Back Pain; Calcitonin; Collagen Diseases; Complement System Proteins; Female; Histocompatibility Antigens; Humans; Hypercalcemia; Hypophosphatemia, Familial; Lupus Erythematosus, Systemic; Male; Osteitis Deformans; Osteomalacia; Parathyroid Hormone; Rheumatic Diseases; Spondylitis, Ankylosing; T-Lymphocytes; Tobramycin; Vitamin D | 1975 |
1 other study(ies) available for tobramycin and Libman-Sacks Disease
| Article | Year |
|---|---|
Case of atypical cutaneous
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tobramycin; Treatment Outcome | 2019 |